Ipca Laboratories Ltd.

Financial

	Ipca Laboratories	JB Chem & Pharma	Alembic Pharma
Operational Metrics
API Sector
US DMF Filings	55.0 .	n/a	132.0 .
Pharmaceutical Sector
Number of ANDA's Filed in USA	44.0 .	19.0 .	260.0 .
Number of ANDA's Approved By USFDA	18.0 .	17.0 .	197.0 .
Domestic Sales Growth - YoY	6.9 %	9.4 %	n/a
R&D as a % of Total Sales	2.71 %	1.55 %	8.0 %
Financials
5 yr Average ROE	15.9 %	18.27 %	15.79 %
5yr average Equity Multiplier	1.41	1.5	1.48
5yr Average Asset Turnover Ratio	0.81	0.79	0.83
5yr Avg Net Profit Margin	13.8 %	15.59 %	13.0 %
Price to Book	4.53	9.48	3.98
P/E	52.45	50.14	31.16
5yr Avg Cash Conversion Cycle	74.74 Days	37.72 Days	1.45 Days
Inventory Days	100.02 Days	52.43 Days	94.67 Days
Days Receivable	55.52 Days	63.16 Days	60.69 Days
Days Payable	120.62 Days	81.2 Days	176.63 Days
5yr Average Interest Coverage Ratio	59.4	74.05	36.16
5yr Avg ROCE	18.97 %	22.31 %	17.34 %
5yr Avg Operating Profit Margin	22.38 %	24.93 %	20.24 %
5 yr average Debt to Equity	0.14	0.06	0.2
5yr CAGR Net Profit	1.13 %	16.2 %	-5.77 %
5yr Average Return on Assets	11.44 %	12.35 %	10.48 %
Shareholdings
Promoter Holding	46.3 %	53.78 %	69.61 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.01 %	-2.13 %	0.13 %
Change in Mutual Fund Holding (3 Yrs)	7.98 %	4.89 %	3.48 %

Business

	Ipca Laboratories	JB Chem & Pharma	Alembic Pharma
Product Wise Break-Up	Product Wise Break-Up Branded Generics 54.13 Active Pharmaceutical Ingredient (API) 24.52 Formulations 21.36 Contract Manufacturing 0 Formulation exported 0 Domestic formulation 0 Formulations 0	Product Wise Break-Up Formulations 30.97 Branded Generics 0 Active Pharmaceutical Ingredient (API) 0 Contract Manufacturing 12.65 Domestic Formulations 53.94 Formulations 0 Others 2.44	Product Wise Break-Up Formulation exported 0 Branded Generics 0 Active Pharmaceutical Ingredient (API) 0 Contract Manufacturing 0 Domestic formulation 0 Formulations 78.25 Others 21.75
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Pain 52.0 Cardiac Science 16.0 Dermatology 6.0 Anti-bacterial 6.0 Cough and colds 5.0 Urology 4.0 Central Nervous System (CNS) 3.0 Anti Malarials 3.0 Gastro Intestinal 2.0 Neutraceuticals 1.0 0 Others 2.0	-	-
Location Wise Break-Up	Location Wise Break-Up India 52.01 Europe 14.15 USA 10.26 Asia Pacific 7.87 Africa 7.68 Australia 4.47 CIS 3.56 Rest of the World 0 Russia 0 South Africa 0	Location Wise Break-Up Africa 0 Australia 0 India 52.06 Asia Pacific 0 South Africa 0 Rest of the World 47.94 Russia 0 Europe 0 USA 0 CIS 0	Location Wise Break-Up Africa 0 Australia 0 India 39.88 Asia Pacific 0 South Africa 0 Rest of the World 60.12 Russia 0 Europe 0 USA 0 CIS 0
Therapeutic Area Break-Up	Therapeutic Area Break-Up Cardiovascular & Anti Diabetics 25.0 Anti Malarials 24.0 NSAID 21.0 Neuro 7.0 GI 6.0 Cough 2.0 Nutraceuticals 0 Urology 0 Dermatology 0 Others 15.0	-	Therapeutic Area Break-Up Anti Malarials 0 Cough 0 Neuro 0 Dermatology 0 NSAID 0 Urology 0 Cardiovascular & Anti Diabetics 0 Nutraceuticals 0 GI 0 Others 100

Ipca Laboratories Ltd.

SIGN UP FOR FREE